This study measured the volume and colour, as weli as concentrations of trypsinogen activation peptides (TAP) in the peritoneal fluid of 22 patients with acute pancreatitis and related these findings to the presence of pancreatic necrosis. Nine patients had a severe attack with histologically confirmed pancreatic necrosis, seven a severe attack without confirmed necrosis, and six a mild attack, also without confirmed necrosis. A free fluid volume >20 ml or free fluid colour >grade 5 on the Leeds chart, or both detected histologically confirmed pancreatic necrosis with a sensitivity of 100% and specificity of 31%. A total peritoneal fluid TAP concentration of ¢96 nmol detected histologically confirmed pancreatic necrosis with a sensitivity of 890/o and specificity of 85%, figures comparable with contrast enhanced computed tomography. These findings suggest that the measurement of peritoneal fluid TAP concentrations can detect effectively histologically confirmed pancreatic necrosis and that such measurements may prove useful in the selection of patients for surgery.
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This occurs in 10 to 15% of patients and is associated with a death rate of 30 to 40%.8 For this reason its early identification and prompt treatment remains an important priority in the treatment of acute pancreatitis.
It has been suggested, although it remains (Table I) .
The three patient groups were comparable in terms of age, sex, aetiology, and hospital stay ( Table I ). The prolonged median stay and lack of differences in the length of hospital stay between the patient groups, was because of two patients with mild disease who remained in for a cholecystectomy and another who had a delayed discharge for social reasons. The total amount of TAP contained within the peritoneal fluid was calculated by multiplying the free fluid TAP concentration by the total volume of fluid aspirated.
Results

TAP CONCENTRATION
The distribution of TAP concentrations within the three groups was not uniform (H=13.10, df= 2, p=0001, Kruskal-Wallis test) (Table  III) . Significantly higher TAP concentrations were seen in the peritoneal fluid of patients with severe pancreatitis associated with confirmed necrosis when compared with patients with severe disease but without confirmed pancreatic necrosis (95.6% CI=0-4 to 9.0 nmol/l, p<0 4) or those with mild Using a cut off value of 96 nmol we could detect pancreatic necrosis with a sensitivity of 89% and specificity of 85% (Fig 2) .
FLUID VOLUME The distribution of fluid volumes within the three groups was not uniform (H=6.47, df=2, p=0 04, Kruskal-Wallis test) (Table III) . There were no significant differences in the volume of fluid obtained from patients with severe attacks with confirmed necrosis and severe attacks without confirmed necrosis (95.6% CI=-390.1 to 189.1 ml, p<0 75) or between those with severe attacks without confirmed necrosis and mild attacks (96.2% CI=-4-1 to 490 ml, p<0-22). Significant differences were seen, however, between patients with severe attacks with confirmed necrosis and mild attacks (96-1% CI=34.9 to 225 ml, p<0 05). A free fluid volume of >20 ml predicted pancreatic necrosis with a sensitivity of 100% (nine of nine patients) but the specificity of only 38% (four of 13 patients).
FLUID COLOUR
The distribution of fluid colour between the three groups was not uniform (H= 13.62, df=2, p=0001, Kruskal-Wallis test) (Table  III ). Significant differences were noted in the colour of fluid samples between those patients with severe attacks with and without confirmed necrosis (95-6% CI=0 to 5, p<003) and severe attacks with confirmed necrosis and mild attacks of acute pancreatitis (96.1% CI=3 to 5, p<0 003). Significant differences were not seen, however, in the fluid colour between patients with severe attacks but without confirmed necrosis and mild attacks of acute pancreatitis (96.2% CI= -1 0 to 3, p=0.3). A free fluid colour of greater than grade 5 selected patients with pancreatic necrosis with a sensitivity of 100% (nine of nine patients) and a specificity of only 46% (six of 13 patients).
Where a patient had >20 ml of free fluid aspirated or free fluid colour darker than grade 5, or both pancreatic necrosis was detected with a sensitivity of 100% and specificity of 31/%. Peritoneal fluid TAP concentrations were noted to be significantly higher in patients with severe acute pancreatitis who had confirmed necrosis than in either of the other two groups. The sensitivity of peritoneal fluid TAP concentrations in detecting histologically confirmed pancreatic necrosis was too low to be clinically useful. A positive predictive value of 100%, however, meant that it did identify correctly all patients with histologically confirmed necrosis. When the peritoneal fluid TAP concentration was multiplied by the free peritoneal fluid volume, a TAP concentration >96 nmol detected pancreatic necrosis with a sensitivity and specificity comparable with the gold standard: contrast enhanced computed tomography.82032 Confirmation that peritoneal fluid TAP concentrations do correlate with disease severity comes from animal experiments.3435 In a study of rats with caerulin induced pancreatitis, the greatest pool of TAP was found within the free peritoneal fluid, concentrations here being significantly higher in non-survivors than in survivors. 35 A total peritoneal fluid TAP concentration of 70 pmol/l predicting the outcome in 94-1 % of animals. Furthermore, peritoneal fluid TAP concentrations proved to be an indicator of the histopathological severity of the disease, TAP concentrations correlating with the presence of intrapancreatic haemorrhage (r=0-57) and acinar cell necrosis (r=0-72).
The reason why raised concentrations of TAP were found in those patients without confirmed necrosis is unclear. It is possible that a degree of trypsinogen activation occurs in oedematous acute pancreatitis. Recently Yamaguchi36 has described, for the first time, trypsinogen activation in rats with caerulin induced pancreatitis put under stress. Fernandez del Castillo et a134 have confirmed these findings by detecting TAP in the urine of rats with caerulin induced pancreatitis. It may be that a similar situation arises in humans. It is also possible that a number of those patients without histologically confirmed necrosis had undetected pancreatic necrosis. Contrast enhanced computed tomography was unavailable during the study period and so it is not possible to exclude pancreatic necrosis in these patients. Despite this it should be remembered that the presence of pancreatic necrosis showed on contrast enhanced computed tomography is not an absolute indication for surgical intervention. A number of authors have shown that even patients with extensive areas of pancreatic hypoperfusion can recover with conservative treatment alone. 17 31 37 38 In addition it is generally agreed that the decision to operate should be based upon a combination of computed tomography findings and assessment of the patients general condition; those with computed tomography confirmed necrosis and a deteriorating clinical condition, or evidence of pancreatic or peripancreatic sepsis being considered suitable for debridement.39 Therefore, we can see that we need to identify correctly those patients with pancreatic necrosis who will require surgery rather than those simply with pancreatic necrosis. In this study a total peritoneal fluid TAP concentration >96 nmol/l identified correctly eight of nine patients who either had or might have benefited from surgery.
In common with other authors' experience15 19 4041 we failed to identify correctly, using clinical evaluation at the time of admission to hospital, a number of patients who were subsequently shown to have suffered a severe attack of acute pancreatitis. This failure will reduce the sensitivity of peritoneal fluid TAP measurements in detecting histologically confirmed pancreatic necrosis. This may, however, not be an important drawback as very few of the patients coming to surgery have an operation during the first week after admission to hospital. If peritoneal fluid TAP concentrations were being used as a means of selecting those patients requiring surgery, then a delay of 48 hours or longer before prediction became available would be acceptable. Such a strategy would also have the advantage of restricting the number of mild cases undergoing peritoneal aspiration. Peritoneal aspiration, when used as a means of severity assessment, has never been accepted widely into clinical practice, perhaps because of its interventional nature and the risk of visceral perforation. 15 If it were possible, however, to identify pancreatic/peripancreatic necrosis, or patients who required surgery, then the balance of risks and benefits would shift in favour of peritoneal aspiration. While this preliminary study suggests that the measurement of peritoneal fluid TAP concentrations can identify patients with confirmed pancreatic necrosis and help in selecting those patients requiring surgery, it should be noted that these findings are retrospective and will require confirmation in a prospective manner before being adopted into clinical practice.
